These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10927766)

  • 21. Hormone replacement therapy and the menopause. Australian Menopause Society.
    MacLennan AH
    Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437
    [No Abstract]   [Full Text] [Related]  

  • 22. Boning up on estrogen: new options, new concerns.
    Insogna K; Concato J; Henrich J
    JAMA; 1996 Nov; 276(17):1430-2. PubMed ID: 8892721
    [No Abstract]   [Full Text] [Related]  

  • 23. [Revised postmenopausal treatments? A new polemic!].
    Foidart JM; Desreux J; Pintiaux A
    Rev Med Liege; 2000 Mar; 55(3):156-60. PubMed ID: 10823005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone therapy in the menopause and breast cancer risk--a review.
    Ewertz M
    Maturitas; 1996 Mar; 23(2):241-6. PubMed ID: 8735362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen replacement therapy and risk of ovarian cancer in postmenopausal women.
    Gilbert L; Krishnamurthy S; Tan SL; Franco EL
    JAMA; 2002 Nov; 288(20):2538-9; author reply 2539. PubMed ID: 12444850
    [No Abstract]   [Full Text] [Related]  

  • 27. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M; Koera K; Nagata H; Nakano H
    J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 29. Hormone replacement therapy in breast cancer.
    DiSaia PJ; Odicino F; Grosen EA; Cowan B; Pecorelli S; Wile AG
    Lancet; 1993 Nov; 342(8881):1232. PubMed ID: 7901541
    [No Abstract]   [Full Text] [Related]  

  • 30. Hormone replacement and breast cancer. A remaining controversy?
    Adami HO; Persson I
    JAMA; 1995 Jul; 274(2):178-9. PubMed ID: 7596008
    [No Abstract]   [Full Text] [Related]  

  • 31. Hormone replacement therapy and breast cancer, revisited.
    Collins J
    J Obstet Gynaecol Can; 2002 May; 24(5):383-8. PubMed ID: 12196858
    [No Abstract]   [Full Text] [Related]  

  • 32. Links between hormone replacement therapy and neoplasia.
    Hulka BS
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy.
    Gambrell RD
    Obstet Gynecol; 1993 Mar; 81(3):477-8. PubMed ID: 8437809
    [No Abstract]   [Full Text] [Related]  

  • 34. Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause? Experimental vs. clinical data.
    Seeger H; Mueck AO
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):11-5. PubMed ID: 18206365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Postmenopausal Estrogen/Progestin Interventions Trial.
    Garg A
    JAMA; 1995 Dec; 274(21):1675-6. PubMed ID: 7474269
    [No Abstract]   [Full Text] [Related]  

  • 36. The controversy over estrogen replacement therapy: an update on clinical trials.
    Gnatuk CL
    Curr Womens Health Rep; 2002 Apr; 2(2):89-94. PubMed ID: 12116607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling the annual costs of postmenopausal prevention therapy: raloxifene, alendronate, or estrogen-progestin therapy.
    Mullins CD; Ohsfeldt RL
    J Manag Care Pharm; 2003; 9(2):150-8. PubMed ID: 14613344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Postmenopausal Estrogen/Progestin Interventions Trial.
    Abrams FR
    JAMA; 1995 Dec; 274(21):1675; author reply 1676. PubMed ID: 7474268
    [No Abstract]   [Full Text] [Related]  

  • 39. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
    Speroff L
    Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer: the role of hormone therapy.
    Creasman WT
    Semin Reprod Med; 2005 May; 23(2):167-71. PubMed ID: 15852202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.